β-肾上腺素能阻滞剂(以下简称β-阻滞剂)应用于临床治疗是本世纪医学治疗史上的重大进展之一。首先推荐此药的学者曾假设β-阻滞剂对心绞痛患者有效益,如今对此已无疑地被证实了。但彼等却未预料到β-阻滞剂的治疗指证在目前会如此广泛(表1)。本药对神经精神和内分泌,以及其他脏器系统的疾患亦有效(表2)。预计今后5年内将生产出对心血管系统呈特异性β-肾上腺素能阻滞剂,对α-肾上 β-adrenergic blockers (hereinafter referred to as β-blockers) for clinical treatment is one of the major advances in the history of medical treatment in this century. Scholars who first recommended the drug had hypothesized that beta-blockers would be beneficial in patients with angina, which is now undoubtedly confirmed. However, they did not anticipate that treatment of beta-blockers will be so widespread so far (Table 1). The drug is also effective for neuropsychiatric and endocrine disorders and other organ systems (Table 2). The next 5 years is expected to produce a specific beta-adrenergic blocker of the cardiovascular system,